M
Medtronic plc (MDT)
NYQ – Real Time Price. Currency in USD
87.14
+0.18 (0.21%)
At close: Mar 27, 2026, 4:00 PM EDT
87.14
0.00 (0.00%)
After-hours: Mar 27, 2026, 7:58 PM EDT
Get all premium features to the best stock analysis tool
NYQ – Real Time Price. Currency in USD
87.14
+0.18 (0.21%)
At close: Mar 27, 2026, 4:00 PM EDT
87.14
0.00 (0.00%)
After-hours: Mar 27, 2026, 7:58 PM EDT
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems and sensors, and InPen, a smart insulin pen. Medtronic plc was founded in 1949 and is headquartered in Galway, Ireland.
| Name | Position |
|---|---|
| Dr. Laura Mauri M.D., M.Sc. | Senior VP and Chief Scientific & Medical Officer |
| Mr. Brett A. Wall | Executive VP & President of Neuroscience Portfolio |
| Mr. Geoffrey Straub Martha | Chairman of the Board & CEO |
| Mr. Jason Weidman | Senior VP and President of Coronary & Renal Denervation business |
| Mr. Mark Ploof | Senior Vice President of Global Operations and Business Services |
| Mr. Matthew R. Walter | SVP of Human Resources and Global Communications & Corporate Marketing |
| Mr. Thierry Pieton | Executive VP & CFO |
| Date | Type | Document |
|---|---|---|
| 2025-11-25 | 10-Q | mdt-20251024.htm |
| 2025-11-18 | 8-K | mdt-20251118.htm |
| 2025-11-03 | 8-K | mdt-20251101.htm |
| 2025-10-24 | 11-K/A | mdt-20251024.htm |
| 2025-10-21 | 8-K | mdt-20251016.htm |
| 2025-10-20 | 11-K | pr202511-k.htm |
| 2025-09-29 | 8-A12B | d55618d8a12b.htm |
| 2025-09-16 | 8-K | d34781d8k.htm |
| 2025-09-04 | ARS | ef20054873_ars.pdf |
| 2025-08-26 | 10-Q | mdt-20250725.htm |
| Ms. Denise L. Blomquist | VP, Global Controller & Chief Accounting Officer |
| Ms. Ingrid Goldberg | Vice President & Head of Investor Relations |
| Ms. Michelle Quinn | Executive VP, General Counsel & Secretary |